• $70.3M
    Market Cap
  • 219.57%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-2.1M
+299.44%
-534,000
N/A
Depreciation and Amortization Expense
342,000
+189.83%
118,000
N/A
Total Operating Expenses
4.1M
+435.94%
768,000
N/A
Operating Profit
-6.2M
+379.95%
-1.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-370,000
N/A
N/A
N/A
Interest Income and Expense and Net
-370,000
N/A
0
N/A
Total Nonoperating Income and Expense
-2.9M
-1,299.18%
243,000
N/A
Income before Taxes
-6.2M
+379.95%
-1.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-3.3M
+115.86%
-1.5M
N/A
Net Income from Continuing Operations Applicable to Common
-3.3M
+115.86%
-1.5M
N/A
Basic EPS and Net Income
4.90
+880.00%
0.50
N/A
Diluted EPS and Net Income
4.90
+880.00%
0.50
N/A
Basic Weighted Average Shares
680,380
-77.25%
3.0M
N/A
Diluted Weighted Average Shares
680,380
-77.25%
3.0M
N/A
Balance Sheet
Cash and Cash Equivalents
1.3M
-48.86%
2.6M
N/A
Short-Term Investments
783,000
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.1M
-18.21%
2.6M
N/A
Total Current Assets
12.9M
+384.73%
2.7M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
12,000
+20.00%
10,000
N/A
Total Long-Term Assets
12,000
+20.00%
10,000
N/A
Total Assets
21.4M
+286.46%
5.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
443,000
+69.73%
261,000
N/A
Total Long-Term Debt
60,000
0.00%
60,000
N/A
Total Long-Term Liabilities
14.8M
+391.73%
3.0M
N/A
Total Liabilities
443,000
+69.73%
261,000
N/A
Retained Earnings
-8.4M
+65.83%
-5.1M
N/A
Total Stockholders Equity
21.0M
+297.16%
5.3M
N/A
Total Shares Outstanding
1.6M
-61.66%
4.2M
N/A
Cash Flow
Cash from Operating Activities
-4.5M
+294.77%
-1.1M
N/A
Capital Expenditures
7,000
N/A
N/A
N/A
Cash from Investing Activities
-16.5M
-57,113.79%
29,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
19.8M
+440.19%
3.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-24.72%
N/A
N/A
N/A
Return on Equity
-25.38%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
29.03
N/A
N/A
N/A
Cash Ratio
2.95
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow